Bohn

Scientists in the Department of Molecular Medicine at The Wertheim UF Scripps Institute delineate the molecular underpinnings of cellular processes and uncover new paths toward therapeutic development. Drawing from disciplines including chemistry, structural biology, pharmacology and genomics, our scientists are making major contributions in the battle against cancer,…

“The compound SR-17018 is the first biased agonist of the mu opioid receptor that does not lead to tolerance with chronic use,” says Stahl, a senior staff scientist in the Bohn lab. “This is a desirable feature for potential use in the context of chronic, severe pain.”